Spotlight
Clinical
CME
Partners
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Dr. Gary Novack: State of glaucoma pharmaceuticals, what future holds
Gary D. Novack, PhD, president of PharmaLogic Development, co-moderated an industry panel discussion on glaucoma pharmaceuticals Friday during Glaucoma 360. Watch Dr. Novack outline the state of glaucoma drug therapy and where the future is headed.
Gary D. Novack, PhD, president of PharmaLogic Development, co-moderated an industry panel discussion on glaucoma pharmaceuticals Friday during the 4th Annual Glaucoma 360 New Horizons Forum. Watch as Dr. Novack outlines the state of glaucoma drug therapy and where the future is headed.
Related Videos
Related Content
